Endocannabinoids and cannabinoid receptor genetics.
Emmanuel S Onaivi, Claire M Leonard, Hiroki Ishiguro, Ping Wu Zhang, Zhicheng Lin, Babatunde E Akinshola, George R. Uhl
Progress in Neurobiology April 2002 DOI: 10.1016/s0301-0082(02)00007-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The review reports that genes encoding CB1 and CB2 cannabinoid receptors have been cloned and that endogenous cannabinoids, along with their enzymes and transporters, have been identified. It argues that these findings, plus CB1/CB2 antagonists and knockout mice, suggest additional G protein-coupled cannabinoid receptors and support further study of cannabinoid gene variants in addiction and neuropsychiatric disorders. |
Abstract
This review presents the remarkable advances that have been achieved in marijuana (cannabinoid) research, with the discovery of specific receptors and the existence of naturally occurring cannabis-like substances in the human body and brain. The last decade has seen more rapid progress in marijuana research than any time in the thousands of years that marijuana has been used by humans, particularly in cannabinoid genomics. The cDNA and genomic sequences encoding G protein-coupled cannabinoid receptors (Cnrs) from several species have now been cloned. Endogenous cannabinoids (endocannabinoids), synthetic and hydrolyzing enzymes and transporters that define neurochemically-specific cannabinoid brain pathways have been identified. Endocannabinoid lipid signaling molecules alter activity at G protein-coupled receptors (GPCR) and possibly at anandamide-gated ion channels, such as vanilloid receptors. Availability of increasingly-specific CB1 and CB2 Cnr antagonists and of CB1 and CB2 Cnr knockout mice have increased our understanding of these cannabinoid systems and provides tantalizing evidence for even more G protein-coupled Cnrs. Initial studies of the Cnr gene structure, regulation and polymorphisms whet our appetite for more information about these interesting genes, their variants and roles in vulnerabilities to addictions and other neuropsychiatric disorders. Behavioral studies of cannabinoids document the complex interactions between rewarding and aversive effects of these drugs. Pursuing cannabinoid-related molecular, pharmacological and behavioral leads will add greatly to our understanding of endogenous brain neuromodulator systems, abused substances and potential therapeutics. This review of CB1 and CB2 Cnr genes in human and animal brain and their neurobiological effects provide a basis for many of these studies. Therefore, understanding the physiological cannabinoid control system in the human body and brain will contribute to elucidating this natural regulatory mechanism in health and disease.
Citations in the library
Cites 4
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America July 31, 2001
- Cannabinoid-induced alterations in brain disposition of drugs of abuse. Biochemical Pharmacology June 1, 2001
- Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse. European Journal of Neuroscience February 2001
- Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science January 15, 1999